Search Results for "naloxone"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for naloxone. Results 11 to 15 of 15 total matches.
Comparison Table: Some Drugs for Maintenance Treatment of Opioid Use Disorder (online only)
The Medical Letter on Drugs and Therapeutics • Sep 04, 2023 (Issue 1684)
,
but efficacy data
with buprenorphine/
naloxone are limited
Buprenorphine
monotherapy is
considered safe ...
View Comparison Table: Some Drugs for Maintenance Treatment of Opioid Use Disorder
Med Lett Drugs Ther. 2023 Sep 4;65(1684):e144-5 doi:10.58347/tml.2023.1684b | Show Introduction Hide Introduction
Opioids for Pain
The Medical Letter on Drugs and Therapeutics • Dec 12, 2022 (Issue 1665)
concurrently with other CNS depressants, especially
benzodiazepines.
The opioid antagonist naloxone should ...
A new CDC guideline for prescribing opioids for pain
recently became available. Nonopioid drugs for pain
were reviewed in a previous issue.
Tramadol Oral Solution (Qdolo) for Pain
The Medical Letter on Drugs and Therapeutics • May 31, 2021 (Issue 1625)
may be at increased risk. Administration of naloxone
for tramadol overdose may increase seizure risk.
Tramadol ...
The opioid agonist tramadol is now available in an oral
solution (Qdolo – Athena Bioscience) for management
of pain severe enough to require an opioid and for
which alternative treatment options are inadequate.
Tramadol has been available for years in immediate-release
tablets and capsules, extended-release
capsules (Ultram, and others), and in a fixed-dose
combination tablet with acetaminophen (Ultracet,
and generics).
An Epinephrine Nasal Spray (neffy) for Anaphylaxis
The Medical Letter on Drugs and Therapeutics • Oct 14, 2024 (Issue 1713)
is the same as that used in several other FDA-approved
nasal sprays, including naloxone (Narcan ...
The FDA has approved an epinephrine nasal spray
(neffy – ARS Pharma) for emergency treatment
of type 1 hypersensitivity reactions including
anaphylaxis in patients who weigh ≥30 kg. It is
the first noninjectable epinephrine product to be
approved for this indication.
Med Lett Drugs Ther. 2024 Oct 14;66(1713):163-4 doi:10.58347/tml.2024.1713b | Show Introduction Hide Introduction
Oliceridine (Olinvyk) - A New Opioid for Severe Pain
The Medical Letter on Drugs and Therapeutics • Mar 08, 2021 (Issue 1619)
, or
pre-existing respiratory depression. These effects
are reversible with naloxone. In the clinical ...
Oliceridine (Olinvyk - Trevena), an IV opioid agonist,
has been approved by the FDA for management of
acute pain severe enough to require an opioid and for
which alternative treatment options are inadequate.